OXT and cancer: For novel DEMs, target genes were mostly enriched in the mitogen-activated protein kinase (MAPK) signaling pathway, Human T-lymphotropicvirus 1 (HTLV-I) infection, oxytocin signaling pathway, axon guidance, microRNAs in cancer, and other pathways (Figure 6B).